Naomi B. Boekel, MSc, discusses the results from a large study that showed that radiation therapy for DCIS does not seem to increase cardiovascular disease risk.
Naomi B. Boekel, MSc, Netherlands Cancer Institute, Amsterdam, Netherlands, discusses the results from a large study that showed that radiation therapy for DCIS does not seem to increase cardiovascular disease risk.
There were two types of comparisons in this analysis, Boekel says. In part of the study, DCIS survivors had a similar risk of dying of any cause, but a 30 percent lower risk of dying from cardiovascular disease compared with the general population.
Additionally, there was no increase in risk for cardiovascular disease between patients who received surgery alone compared with those that received surgery plus radiation (9% versus 8%), or between patients who received left- versus right-sided radiotherapy (7% versus 8%).
Sequencing Sacituzumab and Other Drugs in HR+, HER2- Breast Cancer
May 16th 2024During a Case-Based Roundtable® event, Stephanie L. Graff, MD, discussed multiple later-line treatment options in hormone receptor–positive breast cancer with participants in the first article of a 2-part series.
Read More
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
Darolutamide Becomes Routine Doublet and Triplet Option in Hormone-Sensitive Prostate Cancer
May 6th 2024Darolutamide has been adopted routinely in clinical practice as a component of both doublet and triplet regimens for the treatment of patients with metastatic hormone-sensitive prostate cancer.
Read More